Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Werfen

Download Mobile App




Robotic Partial Nephrectomy Shows Excellent Outcomes

By HospiMedica International staff writers
Posted on 26 Nov 2008
A new study of robotic partial nephrectomy (RPN) shows results that are comparable, if not better, than most traditional laparoscopic procedures.

Researchers at Washington University School of Medicine (Saint Louis, MO, USA) examined and reviewed the patient records and databases of 35 consecutive patients who underwent RPN for suspected renal cell carcinoma, and obtained clinical, pathological, and radiographic data. More...
The study results showed that all 35 patients successfully underwent RPN, while an additional two patients were converted to other nephron sparing procedures. The mean tumor size was 2.8 centimeters in diameter, and mean operating room time was 142 minutes. The mean warm ischemia time was 20 minutes. All margins were negative. There were four complications, and no patients required a return operation. The researchers added that thanks to the new technique, ischemic times are shortened, and that for exophytic small tumors ischemic times are usually under 20 minutes.

The Washington University RPN involves robotic assistance, rapid closure of the collecting system, and renal trauma surgery (renorrhaphy) with sliding nonabsorbable clips; bolsters are rarely used. The procedure evolved from traditional laparoscopic renorrhaphy to a surgeon controlled sliding clip renorrhaphy, which has resulted in added efficiency and tighter closure. The Washington University renorrhaphy is reproducible, resulting in many higher volume robotic surgeons adopting the technique. The researchers preach caution, however, stressing that not every renal tumor should be treated with the same singular technology. In the current era, there is a role for open partial nephrectomy, minimally invasive partial nephrectomy, ablation, and expectant management. Distinguishing amongst these techniques is a challenge, as several patients can do well with any number of modalities. The study was published in the September 24, 2008, edition of BMC Surgery, a publication of Biomed Central.

"Ultimately, the goal of robotic partial nephrectomy is similar to the open counterpart: to provide excellent cancer control with preservation of long-term renal functional outcomes,” concluded co-author Sam Bhayani, M.D., of the department of surgery. "The robot adds a particular amount of efficiency to the procedure, as rapid sewing, similar to the open approach, is the rule.”

Related Links:
Washington University School of Medicine
Biomed Central



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Silver Member
X-Ray QA Device
Accu-Gold+ Touch Pro
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.